Detalles de la búsqueda
1.
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Mult Scler
; 29(14): 1795-1807, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37905526
2.
Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study.
Mult Scler
; 28(8): 1219-1228, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34634968
3.
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
Mult Scler
; 26(13): 1719-1728, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31675266
4.
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.
Mult Scler
; 26(14): 1866-1876, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31762387
5.
Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
Semin Neurol
; 36(2): 140-7, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27116720
6.
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption.
J Neurol
; 271(6): 3116-3130, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615277
7.
Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study.
Ther Adv Neurol Disord
; 16: 17562864231194823, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37745914
8.
Health-Related Quality of Life with Diroximel Fumarate in Patients with Relapsing Forms of Multiple Sclerosis: Findings from Qualitative Research Using Patient Interviews.
Adv Ther
; 39(7): 3199-3213, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35556227
9.
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study.
Adv Ther
; 39(4): 1810-1831, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35211872
10.
A Study Comparing Patient and Clinician Perspectives of Treatments for Multiple Sclerosis via Group Concept Mapping.
Patient Prefer Adherence
; 15: 975-987, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34012257
11.
Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study.
Ther Adv Neurol Disord
; 14: 1756286421993999, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33796143
12.
Clinical and MRI efficacy of sc IFN ß-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS.
J Neurol
; 267(1): 64-75, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31559532
13.
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies.
Neurol Ther
; 9(2): 443-457, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410147
14.
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
JAMA Neurol
; 2020 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852530
15.
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension Study.
CNS Drugs
; 34(9): 973-988, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32710396
16.
The role of natalizumab in the treatment of multiple sclerosis: benefits and risks.
Ther Adv Neurol Disord
; 10(9): 327-336, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28861122
17.
Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors.
Neurol Ther
; 5(2): 155-167, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27277705
18.
Fingolimod for the treatment of relapsing multiple sclerosis.
Expert Rev Neurother
; 13(6): 589-602, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23738997
19.
Initiating oral fingolimod treatment in patients with multiple sclerosis.
Ther Adv Neurol Disord
; 6(4): 269-75, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23858329
20.
Rapid onset mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.
Mult Scler
; 9(1): 59-62, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12617270
Resultados
1 -
20
de 20
1
Próxima >
>>